Improvements in assessment and treatment of diabetic retinopathy position statement
Read More »2017 ADA Position Statement on Diabetic Retinopathy
This represents the first such update by the American Diabetes Association since 2002, and is notable for inclusion of the latest evidence and recommendations with respect to appropriate eye examination intervals, referral criteria, prevention of incidence and progression of diabetic retinopathy (DR), and treatment strategies.
Read More »Metformin in Gestational Diabetes
Should metformin or glyburide, or a combination of both drugs, be the first-line treatment for gestational diabetes?
Read More »Acceptance of Advanced Technologies & Treatments for Diabetes
Is innovative telemedicine the answer to preventing and treating diabetes?
Read More »Recommendations for Insulin Using Patients When Fasting
Can patients who use insulin safely fast?
Read More »Reducing Metabolic Risk Factors By Temporary Fasting
To fast or not to fast.
Read More »A Step Closer To A Cure: Reprogramming Beta Cells
Type 1 beta cells succumb to autoimmunity, leaving significantly reduced beta-cell mass and lifelong dependence on insulin replacement therapy, while type 2 beta cells fail to secrete sufficient insulin to overcome prevailing insulin resistance.
Read More »Preventing Prediabetes from Becoming Diabetes by 80%
In a new international clinical trial, it was shown that the drug liraglutide 3.0 mg may reduce diabetes risk by 80% in individuals with obesity and prediabetes.
Read More »Manage Your Blood Sugar, Control Your Heart
Insulin resistance associated with high blood pressure and other risk factors.
Read More »Continuous Glucose Monitoring: An Adjunct or A Standalone Tool?
Is the use of continuous glucose monitoring alone superior versus its use with the blood glucose monitoring?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.